| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 01/27/2005 | US20050019863 Culture product of Escherichia; transformation with plasmids using Dna sequences |
| 01/27/2005 | US20050019862 Expression vector comprising enzymatic polypeptide for use in prevention and treatment of blood clots; thrombolytic agents |
| 01/27/2005 | US20050019861 genetic engineered hydrolase enzymes used for prophylaxis of Gaucher's disease |
| 01/27/2005 | US20050019854 Analyzing insulin response; solid phase synthesis; for treatment of prediabetes, hyperinsulinemia, and type II diabetes; kits |
| 01/27/2005 | US20050019852 transforming the host cells to express a heterologous, codon-optimized gene encoding a carotene desaturase for the in vivo bioconversion of beta-carotene and/or gamma-carotene into isorenieratene, chlorobactene and/or beta-isorenieratene; Escherichia coli carotene desaturase gene |
| 01/27/2005 | US20050019851 Use of VLCFAE for identifying herbicidally active compounds |
| 01/27/2005 | US20050019823 Using enhanced concentration of transmembrane polypeptide as diagnostic indicator of cell proliferative disorers; diagnosing cancer; antitumor agents |
| 01/27/2005 | US20050019821 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/27/2005 | US20050019816 Process for producing optically active-4-halo-3-hydroxybutanoate |
| 01/27/2005 | US20050019809 drug screening for agonists and antagonists of human type VI adenylyl cyclase (hAC6) polypeptide |
| 01/27/2005 | US20050019789 Thermostable DNA polymerase from anaerocellum thermophilum |
| 01/27/2005 | US20050019783 Method of determining a chemotherapeutic regimen based on glutathione-s transferase pi expression |
| 01/27/2005 | US20050019777 Gene therapy; multi-tissue Northern Blotting; expression vectors; host cells; drug screening; osteoarthritis |
| 01/27/2005 | US20050019771 Novel germinal center kinase proteins, compositions, and methods of use |
| 01/27/2005 | US20050019770 Macroporous gel, its preparing and its use |
| 01/27/2005 | US20050019768 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 01/27/2005 | US20050019766 Nucleotide sequences coding iron sulfur protein (ISP-1) and or cytochrome b locus (CTB-1) protein for use as tool in detection of modulators for treatment, prevention or ameloriation of developmental, behavioral, reproductive and aging disorders |
| 01/27/2005 | US20050019763 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosing, treating, or preventing various disorders |
| 01/27/2005 | US20050019753 Inhibitor-resistant HCV NS3 protease |
| 01/27/2005 | US20050019417 stabilization of proteins, peptides or cells by fluidization of microparticles to form fluidized bed of microparticles comprising water soluble gel forming solid particles, then spraying coating with liquids comprising sugars and solvents, and drying |
| 01/27/2005 | US20050019315 Odor control compositions and methods |
| 01/27/2005 | US20050019307 Therapy gene against mammary gland cancer; transcription control ; Dna |
| 01/27/2005 | DE10332065A1 Enzymatic production of acids with intermediate formation of aldehydes in a single stage reaction from alcohols, involves addition of fresh arylalcohol- arylaldehyde-peroxidases and an oxidant |
| 01/27/2005 | DE10331171A1 Neutrale Protease (NP) und Produkt unter Verwendung von neutraler Protease für Gewebedissoziation sowie Verfahren zu dessen Herstellung Neutral protease (NP) and product using neutral protease for tissue dissociation as well as methods for its preparation |
| 01/27/2005 | CA2536376A1 Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 01/27/2005 | CA2533522A1 Amino acid-substituted coagulation factor v |
| 01/27/2005 | CA2532783A1 Polypeptide having an improved cytosine deaminase activity |
| 01/27/2005 | CA2532186A1 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 01/27/2005 | CA2531709A1 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 01/27/2005 | CA2531695A1 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity |
| 01/27/2005 | CA2531393A1 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 01/27/2005 | CA2530810A1 Genome mapping of functional dna elements and cellular proteins |
| 01/27/2005 | CA2530809A1 Novel phytase and gene |
| 01/27/2005 | CA2525949A1 Transgenic cells expressing proteins involved in fatty acid biosynthesis |
| 01/26/2005 | EP1500704A1 Expression system of actinomycete-origin cytochrome p-450 in escherichia coli |
| 01/26/2005 | EP1500700A2 Pectic acid lyase |
| 01/26/2005 | EP1499740A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/26/2005 | EP1499729A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 01/26/2005 | EP1499728A2 Nucleotide sequence coding for a mannitol 2-dehydrogenase and method for the production of d-mannitol |
| 01/26/2005 | EP1499724A1 Derivatives of the il-2 receptor gamma chain, their production and use |
| 01/26/2005 | EP1499720A2 Gene targeting using replicating dna molecules |
| 01/26/2005 | EP1499719A1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS |
| 01/26/2005 | EP1499718A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/26/2005 | EP1499717A1 Cytotoxicity assay |
| 01/26/2005 | EP1499716A1 Adh from rhodococcus erythropolis |
| 01/26/2005 | EP1499715A1 Aldehyde dehydrogenase ii |
| 01/26/2005 | EP1499714A2 Regulation of human histone acetyltransferase |
| 01/26/2005 | EP1499709A2 Promoter and plasmid system for genetic engineering |
| 01/26/2005 | EP1499642A1 Dna dependent protein kinase catalytic subunit phosphorylation sites and antibodies thereto |
| 01/26/2005 | EP1499632A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/26/2005 | EP1499629A2 Polypeptides having xyloglucanase activity and nucleic acids encoding same |
| 01/26/2005 | EP1499626A2 Solid phase methods for polynucleotide production |
| 01/26/2005 | EP1499350A2 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 01/26/2005 | EP1499343A1 A method of modulating cellular activity |
| 01/26/2005 | EP1499336A2 Protease inhibitors |
| 01/26/2005 | EP1499177A2 Transgenic plants with a suppressed triterpene level |
| 01/26/2005 | EP1430140A4 Isoform-selective inhibitors and activators of pde3 cyclic |
| 01/26/2005 | EP1390484A4 Methods for the identification of inhibitors of pectin esterase expression or activity in plants |
| 01/26/2005 | EP1335989A4 Method for generating recombinant polynucleotides |
| 01/26/2005 | EP1231926B1 Biomolecular complex formed between hyaluronic acid and a biomolecule, its method of manufacture and medical uses thereof |
| 01/26/2005 | EP1149158A4 Genetic and epigenetic regulation of abc transporters and ect0-phosphatases for the modulation of drug resistance |
| 01/26/2005 | EP1071815A4 ASSAY FOR METHYLATION IN THE GST-Pi GENE |
| 01/26/2005 | EP1017835A4 Methods of using cytochrome p450 reductase for the enhancement of p450-based anti-cancer gene therapy |
| 01/26/2005 | EP0748869B1 Ectoine synthetase gene |
| 01/26/2005 | EP0733710B1 Process for producing l-lysine by fermentation |
| 01/26/2005 | EP0725826B1 Improvements relating to cancer therapy |
| 01/26/2005 | EP0655890B1 Recombinant cells, dna constructs, vectors and methods for expression phytate degrading enzymes in desired ratios |
| 01/26/2005 | EP0652946B1 New lipase variants for use in detergent applications |
| 01/26/2005 | EP0451244B9 Subtilisin mutants |
| 01/26/2005 | CN1571843A Nitrile hydratase and a method for producing amides |
| 01/26/2005 | CN1571842A Peptidylarginine deiminase 6 |
| 01/26/2005 | CN1571841A 葡萄糖脱氢酶 Glucose dehydrogenase |
| 01/26/2005 | CN1571839A Gene of enzyme reactivating DNA damaged by ultraviolet light using visible light |
| 01/26/2005 | CN1571837A Microorganisms and processes for enhanced production of pantothenate |
| 01/26/2005 | CN1570151A Method for manufacturing leather from rawhide or epidermis |
| 01/26/2005 | CN1570116A Rhizopus arrhizus delta[12]-fatty acid dehydrogenase nucleic acid sequence and its uses |
| 01/26/2005 | CN1570098A Radioactivity resistant anomalous coccus trehalose synthase gene and trehalose making method |
| 01/26/2005 | CN1570097A Scalper enterokinase catalytic subunit genetic engineering production method and its uses |
| 01/26/2005 | CN1570096A Use of gene recombinant lysozyme #-[134] and gene recombinant human lysozyme and its pure products in antistaling and antiseptic agent |
| 01/26/2005 | CN1570095A Superoxide dismutase complex enzyme industrialized production method using corn as material and its special device for germination |
| 01/26/2005 | CN1570094A Extraction method for SOD complex enzyme coarse powder from corn |
| 01/26/2005 | CN1570093A Extraction method for SOD complex enzyme fine powder from corn |
| 01/26/2005 | CN1570092A Alkaline protease |
| 01/26/2005 | CN1186493C Composite prescription and applied method for alkali pectase preparation |
| 01/26/2005 | CN1186447C Streptomyces avermitilis gene directing ratio of B2:B1 avermectins |
| 01/26/2005 | CN1186446C Streptomyces avermitilis gene directing ratio of B2:B1 avermectins |
| 01/26/2005 | CN1186335C Process for obtaining HMG-CoA reductase inhibitors of high purity |
| 01/25/2005 | USRE38689 Ceramidase gene |
| 01/25/2005 | US6846972 Plant disease resistance genes |
| 01/25/2005 | US6846969 Process for the production of plants with enhanced growth characteristics |
| 01/25/2005 | US6846968 Production of lysosomal enzymes in plants by transient expression |
| 01/25/2005 | US6846920 Comprises nucleotide sequences coding eosinophil protease (EOS) for preparing laundry detergents, stain-removing solutions, skin care products and treating blood and respiratory system disorders |
| 01/25/2005 | US6846912 Monoclonal antibody specific for leukocyte antigen related (LAR) phosphatase for diagnosis and treatment of thyroid cancer insulin resistance and arteriosclerosis |
| 01/25/2005 | US6846910 Dimeric proteins for use in the treatment of cancer |
| 01/25/2005 | US6846805 Oligopeptides or polypeptides used to inhibit transmembrane proteases such as aspartyl secretases, administered for prophylaxis of neurodegenerative diseases; Alzheimer's disease |
| 01/25/2005 | US6846802 Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties |
| 01/25/2005 | US6846672 Mitogenic oxygenase regulators |
| 01/25/2005 | US6846663 Regulation of target protein activity through modifier proteins |
| 01/25/2005 | US6846662 Vertebrate telomerase genes and proteins and uses thereof |
| 01/25/2005 | US6846661 Isolated human UDP-glycosyltransferase, nucleic acid molecules encoding human UDP-glycosyltransferase, and uses thereof |